IDEAYA Biosciences (IDYA) Misses Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts IDYA Hot Sheet
Join SI Premium – FREE
IDEAYA Biosciences (NASDAQ: IDYA) reported Q2 EPS of ($0.88), $0.09 worse than the analyst estimate of ($0.79).
For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Mizuho Starts Sol Gel Technologies Ltd. (SLGL) at Outperform
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
